Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Background: PF-05280586 is being developed as a potential biosimilar to rituximab. Similarity of PF-05280586 to rituximab sourced from the EU and US (rituximab-EU and -US) was assessed using structural, functional, nonclinical pharmacokinetic (PK), tolerability, and toxicity studies, and clinical studies. Methods: Structural similarity was determined by peptide mapping and other analytical methods.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.